Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 9,131 | 13,679 | 8,292 | 10,837 | 11,713 |
| Cost of Goods | 1,934 | 2,241 | 989 | 2,011 | 1,426 |
| Gross Profit | 7,197 | 11,437 | 7,304 | 8,826 | 10,287 |
| Operating Expenses | 11,261 | 13,050 | 10,258 | 9,585 | 9,421 |
| Operating Income | -3,129 | -1,371 | -1,965 | -748 | 1,292 |
| Interest Expense | 86 | 113 | 110 | 110 | 164 |
| Other Income | 78 | 92 | 132 | 128 | 126 |
| Pre-tax Income | -3,137 | -1,392 | -1,943 | -730 | 1,254 |
| Income Tax | 4 | 23 | 6 | 6 | 6 |
| Net Income Continuous | -3,287 | -1,429 | -1,949 | -735 | 1,248 |
| Minority Interests | 3 | -17 | -8 | 6 | -9 |
| Net Income | $-3,290 | $-1,412 | $-1,941 | $-741 | $1,257 |
| EPS Basic Total Ops | -0.22 | -0.09 | -0.13 | -0.05 | 0.08 |
| EPS Basic Continuous Ops | -0.22 | -0.10 | -0.13 | -0.05 | 0.08 |
| EPS Diluted Total Ops | -0.22 | -0.09 | -0.13 | -0.05 | 0.08 |
| EPS Diluted Continuous Ops | -0.22 | -0.10 | -0.13 | -0.05 | 0.08 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.02 | -0.06 | 0.02 | 0.15 |
| EBITDA(a) | $-1,853 | $-329 | $-928 | $286 | $2,324 |